Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats

Free Radical Research

Volumn 46, Issue 5, 2012, Pages 619-627

  Redondo, Anala ^a   Estrella, Natalia ^a   Lorenzo, Andrea Gil ^a   Cruzado, Montserrat ^a   Castro, Claudia ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Angiotensin II; Catechin; Hypertension; Oxidative stress; Quercetin; Smooth muscle cells

Indexed keywords

ANGIOTENSIN II; APOPTOSIS SIGNAL REGULATING KINASE 1; CATECHIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; NITRATE REDUCTASE [NAD(P)H]; PROTEIN P47; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; INCUBATION TIME; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CATECHIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; HYPERTENSION; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; QUERCETIN; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 84859078528     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.660527     Document Type: Article

References (34)

1. Covas MI, Gambert P, Fito M, de la Torre R. Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010;208:297-304.
2. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 2010;31:478-494.
3. Carollo C, Presti RL, Caimi G. Wine, diet, and arterial hypertension. Angiology 2007;58:92-96.
4. Hozumi T, Sugioka K, Shimada K, Kim SH, Kuo MY, Miyake Y, et al. Beneficial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 2006;92:681-682.
5. Karatzi K, Papaioannou TG, Papamichael C, Lekakis J, Stefanadis C, Zampelas A, et al. Red wine, arterial stiffness and central hemodynamics. Curr Pharm Des 2009;15:321-328.
6. Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A, et al. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O- gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 2009;16:1451-1462.
7. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-587.
8. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003;5:155-164.
9. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001;81:999-1030.
10. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, et al. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001;38: 1382-1387.
11. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
12. Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM, et al. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am J Hypertens 2005;18:81-87.
13. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-2579.
14. Cruzado M, Risler N, Castro C, Ortiz A, Ruttler ME. Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels. Am J Hypertens 1998;11:54-58.
15. Pukac L, Huangpu J, Karnovsky MJ. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res 1998;242:548-560.
16. Castro C, Diez-Juan A, Cortes MJ, Andres V. Distinct regulation of mitogen-activated protein kinases and p27Kip1 in smooth muscle cells from different vascular beds. A potential role in establishing regional phenotypic variance. J Biol Chem 2003;278:4482-4490.
17. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004;22:1141-1149.
18. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747.
19. Virdis A, Duranti E, Taddei S. Oxidative stress and vascular damage in hypertension: role of Angiotensin II. Int J Hypertens 2011;2011:916310.
20. Miller SJ, Norton LE, Murphy MP, Dalsing MC, Unthank JL. The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment. Am J Physiol Heart Circ Physiol 2007;292:H2523-H2531.
21. Jiang F, Guo N, Dusting GJ. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3 ' ,4 '-dihydroxyflavonol in phagocytic and vascular cells. J Pharmacol Exp Ther 2008;324:261-269.
22. Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 2011;34:5-14.
23. Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16: 42-47.
24. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292: C82-C97.
25. Clempus RE, Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006;71:216-225.
26. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
27. Alcocer F, Whitley D, Salazar-Gonzalez JF, Jordan WD, Sellers MT, Eckhoff DE, et al. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 2002;131:198-204.
28. Ivanov V, Ivanova S, Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M, et al. Extracellular matrix-mediated control of aortic smooth muscle cell growth and migration by a combination of ascorbic acid, lysine, proline, and catechins. J Cardiovasc Pharmacol 2007;50:541-547.
29. Pignatelli P, Di Santo S, Carnevale R, Violi F. The polyphenols quercetin and catechin synergize in inhibiting platelet CD40L expression. Thromb Haemost 2005;94:888-889.
30. Menendez C, Jimenez R, Moreno L, Galindo P, Cogolludo A, Duarte J, et al. Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle. Br J Nutr 2011;105: 1287-1293.
31. Ndiaye M, Chataigneau M, Lobysheva I, Chataigneau T, Schini-Kerth VB. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redoxsensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J 2005;19:455-457.
32. Iijima K, Yoshizumi M, Hashimoto M, Akishita M, Kozaki K, Ako J, et al. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation 2002;105:2404-2410.
33. Kessler M, Ubeaud G, Jung L. Anti-and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 2003;55:131-142.
34. Cirico TL, Omaye ST. Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation. Food Chem Toxicol 2006;44:510-516.